BPA Call HT001419A0035-HT001420F0023
Award Date
11/6/19
Potential Completion Date
11/5/20
Potential Value
$79K
Federal Agency
Defense Health Agency
Awardee
Cell Marque Corp
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $55,168.14, was issued by the Defense Health Agency (DHA) to Cell Marque Corporation, a manufacturer and supplier of antibodies and reagents for immunohistochemistry. The award is a firm fixed-price Blanket Purchase Agreement (BPA) call for the delivery of various reagents and peripheral consumables, such as the Marque Corp BOB 1 and CD1a antibody reagents. This BPA contract, with a total potential value of $650,000, serves as an indefinite delivery vehicle...
This federal contract award was made by the Defense Health Agency (DHA) to Cell Marque Corp, a for-profit manufacturer of antibodies and reagents for in vitro diagnostic use. The $74,453.00 firm fixed-price contract, issued as a Blanket Purchase Agreement (BPA) call, is for the delivery of specialized laboratory reagents, antibodies, and diagnostic supplies to support medical facilities including Naval Medical Center San Diego and Walter Reed Medical Center. The contract has an ultimate...
This federal contract award is a BPA (Blanket Purchase Agreement) call placed by the Navy Bureau of Medicine and Surgery, a component of the Department of Defense, with Cell Marque Corp. for the delivery of antibody reagents and associated laboratory supplies used in immunohistochemistry testing at military medical facilities. The contract has a ceiling value of $20,000.00 and was awarded on a Firm Fixed Price basis on September 20, 2015, with a period of performance through September 30,...
The Department of the Army Medical Command awarded a blanket purchase agreement (BPA) call contract to Biocare Medical LLC under an existing BPA vehicle. The $25,178.80 firm-fixed-price contract is for the delivery of immunohistochemistry antibodies with a period of performance concluding on June 9, 2021. Awarded without a set-aside designation, the contract supports the agency's medical research and operations at Fort Liberty, North Carolina through the provision of specialized antibody...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Polyscientific Research and Development Corp. to provide reagents and supplies for the agency's Pathology Department. The contract has a potential value of $32,115.85 and requires delivery of the requested products and services by November 10, 2020. Performance will occur in Bethesda, Maryland. No set-aside provision was used for this award to support the Defense Health Agency's...
This is a federal contract award from the Defense Health Agency to Biocare Medical LLC, a for-profit limited liability company and manufacturer of medical equipment and supplies, specifically specializing in immunohistochemistry (IHC) products and automated medical technologies. The contract, valued at $225,275.28, is for the procurement of antibodies and is a firm fixed-price purchase order with a period of performance ending on March 24, 2027. The contract is not set aside for any specific...
This firm fixed price blanket purchase agreement (BPA) call was awarded on September 25, 2020 by the Defense Health Agency to procure medical supplies and equipment in support of the agency's mission. The $100,000 potential value contract was issued without a set-aside designation to Terumo BCT, Inc., doing business as Caridianbct, to fulfill the requirements of the ISSUE CALL FOR MEDICAL SUPPLIES AND EQUIPMENT solicitation. Performance will occur in Bethesda, Maryland through the September...
The Defense Health Agency awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Promega Corporation, a global life sciences company, for the supply of reagents for case work. The contract has a potential value of $15,150.48 and a completion date of September 30, 2024. Promega Corporation is an experienced federal contractor, having provided DNA analysis equipment, reagents, assays, and related laboratory supplies to support biomedical research and testing programs across various...
This is a Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for a (PCR) Molecular Testing System, with a ceiling value of $91,985.40 and a completion date of November 2, 2024. The contract is a Firm Fixed Price type with no set-aside designation. Cepheid is the prime contractor and has been awarded multiple federal contracts and grants, including for the...
Roche Diagnostics Corporation has been awarded a firm fixed price BPA call contract valued at approximately $138,677 by the Defense Health Agency to provide a Ventana Benchmark Ultra Multi-Modal System and ready-to-use reagents. The contract has no set-aside designation and requires performance through September 2022 within Bethesda, Maryland. As the Defense Health Agency oversees healthcare support for military service members, this contract will likely supply diagnostic equipment and...